{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 464200227
| IUPAC_name = 3-(2-diethylaminoethyl)-4-phenylpiperidine-2,6-dione
| image = Phenglutarimide.png

<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 1156-05-4
| ATC_prefix = N04
| ATC_suffix = AA09
| PubChem = 102669
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 92737
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 679RC9H8TG
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07301
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1096643

<!--Chemical data-->
| C=17 | H=24 | N=2 | O=2 
| molecular_weight = 288.385 g/mol
| smiles = CCN(CC)CC[C@]1(CCC(=O)NC1=O)c1ccccc1
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C17H24N2O2/c1-3-19(4-2)13-12-17(14-8-6-5-7-9-14)11-10-15(20)18-16(17)21/h5-9H,3-4,10-13H2,1-2H3,(H,18,20,21)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = BFMBKRQFMIILCH-UHFFFAOYSA-N
}}

'''Phenglutarimide''' (brand names '''Aturbal''', '''Aturbane''') is an [[anticholinergic]] used{{fact|date=August 2012}} as an [[antiparkinsonian]] agent.<ref>{{Cite journal 
| last1 = Battegay | first1 = R. 
| title = [Aturban (phenglutarimide), a new therapeutic drug for parkinsonism; comparative investigation on the therapy of parkinsonism] 
| journal = Schweizerische medizinische Wochenschrift 
| volume = 88 
| issue = 30 
| pages = 740â€“742 
| year = 1958 
| pmid = 13580191|language=German
}}</ref>

== References ==
{{Reflist}}


{{Antiparkinson}}
{{Muscarinic acetylcholine receptor modulators}}

[[Category:Glutarimides]]
[[Category:Muscarinic antagonists]]


{{nervous-system-drug-stub}}